All News
Filter News
Found 24 articles
-
Galecto Appoints Anne Prener to its Board of Directors
1/8/2021
Galecto, Inc., (NASDAQ: GLTO) a NASDAQ listed biotechnology company focused on the development of novel treatments for fibrosis and cancer, today announced the appointment of Dr. Anne Prener to its Board of Directors.
-
BioSpace Movers & Shakers, Sept. 18
9/18/2020
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers. -
Novus Therapeutics Announces Acquisition of Anelixis Therapeutics
9/14/2020
Novus Therapeutics, Inc. (“Novus”) (NASDAQ: NVUS) today announced it has completed the acquisition of Anelixis Therapeutics, Inc. (“Anelixis”), a privately held clinical stage biotechnology company developing a next generation anti-CD40 Ligand (CD40L) antibody as a potential treatment for organ and cellular transplantation, autoimmune diseases, and neurodegenerative diseases
-
Timber Pharmaceuticals Announces Appointment of Dr. Gianluca Pirozzi and Edward J. Sitar to Board of Directors
6/4/2020
Timber Pharmaceuticals, Inc. ("Timber" or the “Company”) (NYSE American: TMBR), a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases, today announced the appointment of Gianluca Pirozzi, M.D., Ph.D. and Edward J. Sitar t